Use of gemtuzumab ozogamycin combined with conventional chemotherapy in patients with acute myeloid leukemia
Objective: To analyze the outcome of patients treated with gemtuzumab ozogamycin combined with conventional therapy treated at Hospital Israelita Albert Einstein. Methods: 14 patients who had high risk features (secondary leukemia, unfavorable cytogenetics, and refractory disease) were treated with...
|Other Authors:||, , , , , , , , |
|Document type:|| Article
Instituto Israelita de Ensino e Pesquisa Albert Einstein